Search Results 191-200 of 23009 for Phase

  1. The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis - Mayo Clinic

    About this study. This is a global, multicenter, Phase 2b, randomized, double-blind, placebo-controlled, two-arm, parallel-group efficacy and safety study ...

  2. Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF Bronchiectasis - Mayo Clinic

    Clinical Trials · Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF Bronchiectasis · More about research at Mayo Clinic · Mayo Clinic Footer.

  3. Delayed sleep phase - Doctors and departments - Mayo Clinic

    Publications. See a list of publications about delayed sleep phase by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

  4. A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant ...

  5. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    About this study. The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab ...

  6. A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma - Mayo Clinic

    A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma · Overview · Participation eligibility · Participating Mayo Clinic ...

  7. Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis - Mayo Clinic

    Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis · Overview · Participation eligibility · Participating Mayo Clinic locations.

  8. ICoN-1 Phase 3 Study Of The Efficacy And Safety Of Treatment With MNKD-101, Clofazimine Inhalation Suspension - Mayo Clinic

    Clinical Trials · ICoN-1 Phase 3 Study Of The Efficacy And Safety Of Treatment With MNKD-101, Clofazimine Inhalation Suspension · More about research at Mayo ...

  9. Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis - Mayo Clinic

    Expansion phase to evaluate safety, efficacy and pharmacokinetics of NEOD001 in 25 additional subjects at the maximum tolerated dose. Participation eligibility.

  10. A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis - Mayo Clinic

    PRM-151 is an investigational drug that is being developed for possible use in the treatment of myelofibrosis (MF), a disease in which the bone marrow, which is ...